Alps Advisors Inc Gilead Sciences, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 308,413 shares of GILD stock, worth $27.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

308,413

Previous 392,868 21.5%

Holding current value

$27.7 Million

Previous $27 Million 4.09%

% of portfolio

0.17%

Previous 0.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $5.62 Million - $7.09 Million	-84,455 Reduced 21.5%	308,413 $25.9 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $2.42 Million - $2.8 Million	38,400 Added 10.83%	392,868 $27 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $1.73 Million - $2.11 Million	24,189 Added 7.32%	354,468 $26 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $1.35 Million - $1.53 Million	-18,412 Reduced 5.28%	330,279 $26.8 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $788,939 - $860,748	10,670 Added 3.16%	348,691 $26.1 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $816,879 - $931,764	-10,747 Reduced 3.08%	338,021 $26.1 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $1.72 Million - $1.95 Million	22,189 Added 6.79%	348,768 $28.9 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $5.84 Million - $8.38 Million	-93,658 Reduced 22.29%	326,579 $28 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $6.56 Million - $7.5 Million	-110,237 Reduced 20.78%	420,237 $25.9 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $6.55 Million - $7.38 Million	113,539 Added 27.23%	530,474 $32.8 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $4.68 Million - $5.87 Million	80,853 Added 24.06%	416,935 $24.8 Million
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $28,806 - $32,696	-444 Reduced 0.13%	336,082 $24.4 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $1.95 Million - $2.11 Million	-28,825 Reduced 7.89%	336,526 $23.5 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $619,276 - $676,647	-9,757 Reduced 2.6%	365,351 $25.2 Million
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $2.17 Million - $2.48 Million	36,155 Added 10.67%	375,108 $24.2 Million
Q4 2020 Feb 03, 2021	BUY	$56.65 - $64.55 $3.38 Million - $3.85 Million	59,664 Added 21.36%	338,953 $19.7 Million
Q3 2020 Nov 04, 2020	BUY	$62.1 - $78.08 $566,289 - $712,011	9,119 Added 3.38%	279,289 $17.6 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $2.9 Million - $3.37 Million	-40,070 Reduced 12.92%	270,170 $20.8 Million
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $14.6 Million - $18.7 Million	-233,564 Reduced 42.95%	310,240 $23.2 Million
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $378,038 - $415,830	6,135 Added 1.14%	543,804 $35.3 Million
Q3 2019 Nov 04, 2019	BUY	$62.51 - $69.0 $213,534 - $235,704	3,416 Added 0.64%	537,669 $34.1 Million
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $3.72 Million - $4.18 Million	-60,185 Reduced 10.12%	534,253 $36.1 Million
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $1.61 Million - $1.8 Million	-25,712 Reduced 4.15%	594,438 $38.6 Million
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $2.85 Million - $3.72 Million	-47,101 Reduced 7.06%	620,150 $38.8 Million
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $1.84 Million - $2.04 Million	-25,839 Reduced 3.73%	667,251 $51.5 Million
Q2 2018 Aug 02, 2018	BUY	$64.88 - $75.68 $1.37 Million - $1.59 Million	21,051 Added 3.13%	693,090 $49.1 Million
Q2 2018 Jul 25, 2018	BUY	$64.88 - $75.68 $2.08 Million - $2.43 Million	32,101 Added 5.02%	672,039 $48.1 Million
Q1 2018 May 01, 2018	SELL	$72.84 - $88.8 $2.34 Million - $2.85 Million	-32,101 Reduced 4.78%	639,938 $48.2 Million
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $46 Million - $54 Million	646,350 Added 2516.06%	672,039 $48.1 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $1.85 Million - $2.2 Million	25,689	25,689 $2.08 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Gilead Sciences, Inc. Transaction History